Učitavanje...
抗CD19 CAR-T细胞治疗难治复发B细胞肿瘤10例临床分析
OBJECTIVE: To investigate the outcomes of anti-CD19 CAR-T cell for relapsed and refractory B cell malignancies. METHODS: Ten patients with relapsed and refractory B cell acute lymphocytic leukemia (B-ALL) and non-Hodgkin's lymphoma (NHL), diagnosed in the Department of Hematology of Peking Univ...
Spremljeno u:
| Izdano u: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Editorial office of Chinese Journal of Hematology
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342922/ https://ncbi.nlm.nih.gov/pubmed/30032559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.06.003 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|